Cardiovascular diseases, particularly myocardial infarction (MI), are the leading cause of mortality and morbidity around the globe. Because cardiac tissue possesses very limited regeneration potential, use of a potent small molecule, inhibitor Wnt production-4 (IWP-4) for stem cell differentiation into cardiomyocytes could be a promising approach for cardiac regeneration.
